Guardian Pharmacy Services (NYSE:GRDN) Price Target Raised to $24.00 at Truist Financial

Guardian Pharmacy Services (NYSE:GRDN - Free Report) had its price objective raised by Truist Financial from $22.00 to $24.00 in a research note published on Friday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Other research analysts have also issued research reports about the stock. Stephens assumed coverage on shares of Guardian Pharmacy Services in a report on Tuesday, October 22nd. They issued an "overweight" rating and a $21.00 price target on the stock. Raymond James assumed coverage on shares of Guardian Pharmacy Services in a research report on Monday, October 21st. They issued an "outperform" rating and a $21.00 price objective for the company.

Guardian Pharmacy Services Trading Down 0.3 %

Shares of GRDN stock traded down $0.07 during trading hours on Friday, hitting $20.93. 68,722 shares of the company were exchanged, compared to its average volume of 157,017. Guardian Pharmacy Services has a 1 year low of $14.16 and a 1 year high of $23.05.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by ($2.19). The company had revenue of $314.39 million for the quarter, compared to analysts' expectations of $303.21 million. On average, equities research analysts forecast that Guardian Pharmacy Services will post 0.79 EPS for the current year.

Insider Buying and Selling at Guardian Pharmacy Services

In related news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the firm's stock in a transaction dated Friday, September 27th. The stock was acquired at an average price of $14.00 per share, with a total value of $499,996.00. Following the completion of the transaction, the director now owns 35,714 shares of the company's stock, valued at $499,996. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of hedge funds have recently added to or reduced their stakes in the business. Seven Grand Managers LLC bought a new stake in Guardian Pharmacy Services in the third quarter valued at $2,515,000. Allspring Global Investments Holdings LLC bought a new stake in Guardian Pharmacy Services in the third quarter valued at $5,460,000. Stephens Inc. AR bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at about $189,000. Royce & Associates LP bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at about $1,260,000. Finally, Foundry Partners LLC bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at about $1,680,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.